Amendment No. 2 to the OUS Commercialization AgreementOus Commercialization Agreement • August 3rd, 2011 • Dexcom Inc • Surgical & medical instruments & apparatus
Animas Corporation, a Delaware Corporation, having a principal place of business at 200 Lawrence Drive, West Chester, PA 19380 (“Animas” or “Distributor”) and DexCom, Inc., a Delaware corporation, having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (“DexCom”), are parties to the OUS Commercialization Agreement dated January 12, 2009 (the “OUS Commercialization Agreement”), as amended on July 31, 2009 (“Amendment One”). Pursuant to Section 18.02 of the OUS Commercialization Agreement, the parties hereby wish to amend the OUS Commercialization Agreement as set forth below (“Amendment Two”). All terms not defined herein shall have the meaning set forth in the OUS Commercialization Agreement.
